Literature DB >> 11444383

IL-4 signaling, gene transcription regulation, and the control of effector T cells.

M Boothby1, A L Mora, M A Aronica, J Youn, J R Sheller, S Goenka, L Stephenson.   

Abstract

The central goal of our laboratory is to understand the regulation of lymphoid cells through molecular mechanisms of signal transduction and transcriptional control. A long-standing focus has been on changes that influence the effector function of mature lymphocytes. Work in the laboratory is oriented toward the identification of new regulatory mechanisms using cell lines and primary cells, and the validation of these in vitro findings in mouse models of immune responses and diseases. In this review, we summarize key insights into the regulation of T helper cell function during the phase of immunity where effector responses arise de novo. Particular interest has been centered on cytokine gene regulation as part of T cell differentiation into the Th1 and Th2 subsets. Information on IL-4 receptor signaling and the role of NF-kappaB transcription factors is reviewed. Our more recent work is designed to understand how regulation at the Th1/2 effector stages is related to the control of memory T cell survival, immune recall responses, and the role of these responses in immune-mediated disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11444383     DOI: 10.1385/IR:23:2-3:179

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  79 in total

Review 1.  Immunologic basis of antigen-induced airway hyperresponsiveness.

Authors:  M Wills-Karp
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

2.  Functional characteristics and survival requirements of memory CD4+ T lymphocytes in vivo.

Authors:  C A London; V L Perez; A K Abbas
Journal:  J Immunol       Date:  1999-01-15       Impact factor: 5.422

3.  IL-4 and IL-13 production in differentiated T helper type 2 cells is not IL-4 dependent.

Authors:  H Huang; J Hu-Li; H Chen; S Z Ben-Sasson; W E Paul
Journal:  J Immunol       Date:  1997-10-15       Impact factor: 5.422

4.  IL-4 rapidly produced by V beta 4 V alpha 8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice.

Authors:  P Launois; I Maillard; S Pingel; K G Swihart; I Xénarios; H Acha-Orbea; H Diggelmann; R M Locksley; H R MacDonald; J A Louis
Journal:  Immunity       Date:  1997-05       Impact factor: 31.745

5.  Involvement of IL-4-producing Vbeta8.2+ CD4+ CD62L- CD45RB- T cells in non-MHC gene-controlled predisposition toward skewing into T helper type-2 immunity in BALB/c mice.

Authors:  T Nishimura; K Santa; T Yahata; N Sato; A Ohta; Y Ohmi; T Sato; K Hozumi; S Habu
Journal:  J Immunol       Date:  1997-06-15       Impact factor: 5.422

6.  An interleukin 4 (IL-4)-independent pathway for CD4+ T cell IL-4 production is revealed in IL-4 receptor-deficient mice.

Authors:  N Noben-Trauth; L D Shultz; F Brombacher; J F Urban; H Gu; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

7.  Paired Stat6 C-terminal transcription activation domains required both for inhibition of an IFN-responsive promoter and trans-activation.

Authors:  S Goenka; J Youn; L M Dzurek; U Schindler; L Y Yu-Lee; M Boothby
Journal:  J Immunol       Date:  1999-11-01       Impact factor: 5.422

8.  CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes.

Authors:  D J Lenschow; K C Herold; L Rhee; B Patel; A Koons; H Y Qin; E Fuchs; B Singh; C B Thompson; J A Bluestone
Journal:  Immunity       Date:  1996-09       Impact factor: 31.745

9.  Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.

Authors:  D K Dalton; S Pitts-Meek; S Keshav; I S Figari; A Bradley; T A Stewart
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

10.  An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth.

Authors:  A D Keegan; K Nelms; M White; L M Wang; J H Pierce; W E Paul
Journal:  Cell       Date:  1994-03-11       Impact factor: 41.582

View more
  7 in total

1.  Helminth regulation of host IL-4Ralpha/Stat6 signaling: mechanism underlying NOS-2 inhibition by Trichinella spiralis.

Authors:  Ka Bian; Meng Zhong; Yael Harari; Mildred Lai; Norman Weisbrodt; Ferid Murad
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-01       Impact factor: 11.205

2.  Regulation of IL-13 synthesis in human lymphocytes: implications for asthma therapy.

Authors:  Andreas Pahl; Meixia Zhang; Hildegard Kuss; Istvan Szelenyi; Kay Brune
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

3.  A selective novel low-molecular-weight inhibitor of IkappaB kinase-beta (IKK-beta) prevents pulmonary inflammation and shows broad anti-inflammatory activity.

Authors:  Karl Ziegelbauer; Florian Gantner; Nicholas W Lukacs; Aaron Berlin; Kinji Fuchikami; Toshiro Niki; Katsuya Sakai; Hisayo Inbe; Keisuke Takeshita; Mina Ishimori; Hiroshi Komura; Toshiki Murata; Timothy Lowinger; Kevin B Bacon
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

4.  Construction of a recombinant adenovirus vector expressing IL-18BP/IL-4 fusion gene and the anti-inflammatory effect induced by this gene on lipopolysaccharide-stimulated synovial fibroblasts.

Authors:  Hang-Ping Yao; Yun Qian; Xue-Ting Shao; Zhe-Rong Xu; Lin-Fang Cheng; Lei Feng; Nan-Ping Wu; Yun-Mei Yang
Journal:  Inflamm Res       Date:  2009-11-22       Impact factor: 4.575

5.  Induction of interleukin-12 production in mouse macrophages by berberine, a benzodioxoloquinolizine alkaloid, deviates CD4+ T cells from a Th2 to a Th1 response.

Authors:  Tae S Kim; Bok Y Kang; Daeho Cho; Seung H Kim
Journal:  Immunology       Date:  2003-07       Impact factor: 7.397

6.  Identification of differentially expressed genes in cutaneous squamous cell carcinoma by microarray expression profiling.

Authors:  Ingo Nindl; Chantip Dang; Tobias Forschner; Ralf J Kuban; Thomas Meyer; Wolfram Sterry; Eggert Stockfleth
Journal:  Mol Cancer       Date:  2006-08-08       Impact factor: 27.401

7.  Incorporation of membrane-bound, mammalian-derived immunomodulatory proteins into influenza whole virus vaccines boosts immunogenicity and protection against lethal challenge.

Authors:  Andrew S Herbert; Lynn Heffron; Roy Sundick; Paul C Roberts
Journal:  Virol J       Date:  2009-04-24       Impact factor: 4.099

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.